Abstract: Detection of micrometastases plays an important role in early-stage and recurrent cancer diagnosis. In the study, a new method of screening micrometastases of lung cancer in peripheral blood by magnetic nanoparticles (MNPs) and quantum dots (QDs) was developed to achieve early diagnosis and recurrence prevention. MNPs were prepared by combining miniemulsion polymerization and Stöber coating methods. QDs were prepared by using Cd(Ac) 2 ⋅ 2H 2 O and oxygen-free NaHTe with thioglycolic acid as the stabilizer. The carbodiimide-mediated condensation method was used to couple pan-cytokeratin (pan-ck) antibody (Ab) to the surface of the MNPs, and Lunx and SP-A Abs to the surface of the QDs. After four kinds of epithelial tumor cells were enriched by MNPs coupled with pan-ck Ab (MNP-pan-ck), lung cancer cells A549 and SPC-A-1 were successfully identified by QDs with double-labeled Abs. Finally, 32 patients with non-small cell lung cancer (NSCLC) were collected, out of 26 cases with the enriched circulating tumor cells (CTCs), 21 cases were successfully identified by QDs. Therefore, a new method was established in which MNP-pan-ck collected CTCs and QDs with double-labeled Abs could be used simultaneously to identify CTCs from NSCLC patients.
Introduction
Lung cancer is the leading cause of cancer deaths worldwide. International standards divide lung cancer into two types: small cell lung cancer and non-small cell lung cancer (NSCLC). NSCLC accounts for approximately 85% of all cases of lung cancer. Surgery is the preferred treatment method for NSCLC patients. However, many patients remain at risk of recurrence and metastasis following surgery, and it is difficult for routine histopathology and imageology methods to detect metastasis. Therefore, more sensitive and specific methods are needed to detect lung cancer earlier and identify patients at highest risk for recurrence. In 2002, Bernards and Weinberg 1 presented a new model of metastasis where metastatic capacity is gained early during primary tumor development. Micrometastases were originally defined by pathologists as small occult metastases (0.2 cm in their greatest dimension). Currently, single circulating tumor cells (CTCs) are also called micrometastases. Indeed, single CTCs in cancer patients can be detected at early stages of tumor progression in peripheral blood. In order to detect single CTCs in peripheral blood, several different methods have been developed including reverse-transcription polymerase chain reaction, flow cytometry, and the immunomagnetic beads technique.
To date, nanomaterials and nanotechnology have shown great potential in disease diagnosis and therapy. Magnetic nanoparticles (MNPs) are a new type of nanomaterial. 8 The application of MNPs in the fields of biomedicine such as magnetic separation, drug delivery, magnetic resonance imaging, cell and tissue targeting, and transfection have drawn considerable attention due to their particularly large surface-to-volume ratio and intrinsic magnetic properties. 9, 10 Quantum dots (QDs) are nanocrystals of inorganic semiconductors that are restricted in three dimensions to a somewhat spherical shape, typically with a diameter of 2-8 nm. 11 QDs are a relatively new class of fluorescent nanomaterials with excellent photophysical properties which include quantum-size effect, high brightness, long-term photostability, high quantum yields, and more importantly, broad absorption spectra coupled to narrow size-tunable photoluminescent emission spectra. 12 These properties and advantages of MNPs and QDs have provided a new functional platform for disease diagnosis and therapy.
It is well known that NSCLC is a type of epithelial cancer. Pan-cytokeratin (pan-ck) are currently the usual protein markers for the detection of epithelial tumor cells. 13 Lunx, a novel human lung-specific gene, has been reported to be a superior diagnostic marker for the detection of micrometastases in peripheral blood and lymph nodes of NSCLC patients.
14 Surfactant protein-A (SP-A) is the most prominent of the four proteins in the pulmonary surfactant system. Moreover, expression of SP-A was also described for a portion of NSCLC facilitating a diagnostic marker for these carcinomas. 15, 16 Since CTCs have very low concentration in the blood (1 per 10 6-7 leukocytes), a primary enrichment step must usually be performed to augment the sensitivity of the assay. 17 This will be followed by a detection method that will identify CTCs. In the present study, new modified MNPs coupled with pan-ck Ab (MNP-pan-ck) are prepared to enrich peripheral blood CTCs in NSCLC patients. After the CTCs are isolated with the MNPs, QDs conjugated with Lunx and SP-A Ab are used to identify the CTCs.
Materials and methods

Preparation and modification of MNPs
Iron oxide (Fe 3 O 4 ) MNPs were prepared by coprecipitation of FeCl 2 /FeCl 3 (ratio 1:2) by the Massart method. 18 Oleic acid (OA)-modified MNPs were produced by redispersing Fe 3 O 4 MNP precipitate in 150 mL of water and adding an excess amount of OA. 19 The dark suspension was stirred for 1 hour at 70°C under the protection of N 2 . The oily black precipitate was collected, washed three times with water, and then dried in an oven under the protection of N 2 . Miniemulsion polymerization was used to prepare Fe 3 O 4 /polystyrene MNPs according to the following procedure: 20 Fe 3 O 4 MNPs were modified by 0.11 g of OA and were dispersed in a solution of 1 mL of styrene and 0.1 g of cyclohexane with the aid of ultrasound to form the oil phase. 80 mg of sodium dodecyl sulfate (SDS) and 8 mg sodium bicarbonate were dissolved in 30 mL of water to form the water phase. A mixture of the oil phase and the water phase was ultrasonicated in an ice-cooled bath for 10 minutes to form a miniemulsion and was transferred to a 250 mL four-necked flask equipped with a condenser, a nitrogen inlet, and a stirrer. 15 mg of potassium persulfate dissolved in 0.5 mL of water was added to initiate the polymerization at 70°C with continual stirring at 300 rpm (magnetic stir bars, 25 mm × 9 mm). 
Preparation and modification of aqueous soluble CdTe QDs
Cadmium telluride (CdTe) QDs were synthesized according to the method reported by Zhao. 21 Briefly, 0.5 mmol Cd(Ac) 2 ⋅ 2H 2 O (Beijing Chemical Int., Beijing, China) was dissolved in 100 mL of high-purity water, then 87 µL of thioglycolic acid (Acros, Geel, Belgium) was added into the mixture under stirring. 1 M NaOH was used to adjust the pH of the solution to 9.5. After the mixture had been degassed by high-purity N 2 bubbling for 30 minutes, a 0.25 mmol oxygen-free NaHTe (Beijing Chemical Int.) solution prepared by reducing Te powder by NaBH 4 was injected. The resulting mixture was subjected to reflux until the appreciated size was reached by monitoring the ultraviolet-visible curves of the aliquot. Fluorescence spectra of CdTe QDs were measured on a FS900 fluorescence spectrometer (Edinburgh Analytical Instruments, Edinburgh, UK). High-resolution transmission electron microscope (HRTEM) characterizations were performed by using a JSM-3010 (JEOL, Tokyo, Japan) electron microscope. In the experiment, two kinds of CdTe QDs were synthesized, and were named QD552 and QD625, respectively, based on the maximum fluorescence emission of the QDs.
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Coupling pan-ck Ab to the surface of MNPs
The carbodiimide-mediated condensation method was used to couple pan-ck Ab to the surface of MNPs. Briefly, 100 µL of MNPs were transferred to a reaction tube and coupling buffer (10 mM K 2 HPO 4 , 150 mM NaCl, pH 5.5) was added to a final volume of 1 mL. The reaction tube was shaken vigorously for 1 minute and then the MNPs were separated magnetically by placing the reaction tube in the magnetic separator (Dynal AS, Oslo, Norway) at 4°C for 5 minutes. The supernatant was removed, leaving the MNPs as a wet cake on the container wall. The MNPs were suspended in 1 mL of coupling buffer. 0.25 mg 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC) reagent (Sigma-Aldrich, St Louis, MO) was added to the system and stirred briefly. 50 µg pan-ck Ab was added to the reaction system and vortexed for 1 hour. The MNP-pan-ck was magnetically separated and the supernatant was removed. 1 mL of wash buffer (10 mM Tris, 150 mM NaCl, 0.1% BSA, 0.1% NaN 3 , 1 mM EDTA, pH 7.4) was added and shaken vigorously. The wash step was repeated three times. Finally, the MNP-pan-ck was resuspended in the wash buffer.
Coupling Abs to the surface of CdTe QDs
The resultant CdTe QDs were conjugated to different lung tissue-specific Abs. QD552 was conjugated to rabbit antihuman Lunx Ab (QD552-Lunx) and QD625 was conjugated to rabbit anti-human SP-A Ab (QD625-SP-A) (Santa Cruz Biotechnology, Santa Cruz, CA). Briefly, 100 µL of 1 mM CdTe QD solution was mixed with 400 µL of 0.05 M borate buffer (pH 7.5). Then, 10 µL of 25 mg/mL EDAC freshly dissolved in water was added to a mixture. After incubation for 5 minutes, 20 µg Ab was added to the mixture. The sample was dialyzed against phosphate-buffered saline (PBS; 10 mM, pH 7.4) after incubation in the dark for 2 hours at room temperature. When the dialysis was over, the QDs conjugated to Abs were collected.
Enriching of epithelial cancer cells by MNPs
Lung cancer A549, SPC-A-1, liver cancer HepG2, and colon cancer HCT-8 cell lines were obtained from American Type Culture Collection (Manassas, VA). All cells were maintained in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum and were grown in 5% CO 2 . MNPs-pan-ck were added to the cell suspension and mixed gently for 15 minutes. Cancer cells originating from epithelial tumors were magnetically separated and the isolated cells were resuspended using PBS buffer, and then the separated cells were smeared onto a slide. The slides were stained with hematoxylin and eosin (H&E) to identify cancer cells.
Identification of lung cancer cells by immunocytochemistry
A549, SPC-A-1, HepG2, and HCT-8 cells were fixed with a mixture of glacial acetic acid:ethanol (volume ratio of 1:9) for 15 minutes and air-dried for 30 minutes. Fixed cancer cells were penetrated with 0.3% Triton X-100 for 10 minutes. The cells were respectively blocked with H 2 O 2 reagent and normal goat serum for 10 minutes followed by incubating the slides with 1 µg/mL rabbit anti-human Lunx or SP-A Ab at 4°C overnight. 1.5 µg/mL biotinylated goat anti-rabbit IgG was incubated for 30 minutes, and then streptavidin-conjugated horseradish peroxidase was incubated for 30 minutes. Staining was achieved by adding 100 µL of 3,3′diaminobenzidine for 5 minutes. Finally, slides were washed three times with PBS buffer, the nuclei were counterstained with H&E, and then slides were rinsed with water and dehydrated in 70%, 90%, and 100% ethanol, air-dried, and mounted with gum and viewed under an ordinary optical microscope.
Identifying lung cancer cells with double-labeled Lunx and sP-A Abs QDs
After using MNP-pan-ck to enrich the epithelial cancer cells, all cells were identified by using QD552-Lunx and QD625-SP-A Abs QDs. Briefly, enriched cells were incubated with QD552-Lunx and QD625-SP-A Abs at 4°C overnight. Slides were washed three times with PBS buffer, mounted with glycerin reagent, and viewed under fluorescent microscope (Olympus, Tokyo, Japan).
Clinical specimens
Thirty-two patients with primary NSCLC were enrolled between May 2011 and October 2011 at China-Japan Union Hospital, including 16 males and 16 females aged between 45-77 years old. Thirty-two patients were confirmed to have NSCLC after surgical inspection and were diagnosed without history of other epithelial tumors. NSCLC patients were staged using the tumor-node-metastasis system, including submit your manuscript | www.dovepress.com Dovepress Dovepress seven cases of stage I and 25 cases of stage II-IV. Moreover, 16 patients with benign lung diseases (BLD) and 16 healthy volunteers were enrolled as controls. 10 mL of blood was collected from all participants and PBMC were isolated by density gradient centrifugation. CTCs were enriched from PBMC by MNP-pan-ck and identified by QDs with doublelabeled Abs. The study was approved by the Institutional Review Board of the University Hospital. All samples were collected after obtaining written informed consent.
statistical analysis
All the data were analyzed with SPSS software (v 12.0; SPSS Inc, Chicago, IL). Experiments were performed in triplicate. Results were expressed as mean ± standard error of mean. Statistical significance was set as P , 0.05.
Results and discussion
Characterization of MNPs
Many approaches have been employed to prepare MNPs including conventional emulsion polymerization, 22 soapless emulsion polymerization, 23, 24 inverse emulsion polymerization, 25 miniemulsion polymerization, 26 and atom transfer radical polymerization. 27, 28 Among them, miniemulsion polymerization has been considered as one of the most advantageous encapsulation methods. In the present study, the MNPs with defined structure and controllable magnetite content were successfully prepared from monolayer OAmodified Fe 3 O 4 nanoparticles through miniemulsion poly -merization. Figure 1 illustrates the TEM images of different synthetic phases of the MNPs. Figure 1A Figure 1D shows the carboxylfunctionalized Fe 3 O 4 /polystyrene MNPs. A polyacrylic acid layer surfaces the Fe 3 O 4 /polystyrene MNPs, which gives a fine hydrophily and biocompatibility to the MNPs.
Characterization of CdTe QDs
Several methods have been developed to synthesize watersoluble QDs for use in biologically relevant studies. 29, 30 In the present experiment, two kinds of CdTe QDs were synthesized (Figure 2) . In Figure 2A , two kinds of QDs emit different colors under UV radiation: one emits green light and the other emits red light. The HRTEM study illustrates that the diameter of CdTe QDs ranges from 2.8 nm to 7.3 nm with an average size of 4 nm, which suggests that the CdTe QDs exhibit a good dispersion of particles, and no obvious QD aggregation can be found ( Figure 2B ). The fluorescence emission spectra of the CdTe QDs are shown in Figure 2C . The maximum fluorescence emission of two kinds of QDs are respectively 552 nm and 625 nm, which were named after QD552 and QD625 in this study. The average full width at half the maximum of the photoluminescence spectra is about 50 nm, which shows that the monodispersity of the QDs is quite good. The two kinds of QDs have a broader absorption spectra which show that a single light source can be used to excite two-color QDs simultaneously without signal overlap ( Figure 2D ). Therefore, due to these properties, the synthesized QDs provided a powerful foundation for further applications.
MNP-pan-ck enriched epithelial tumor cells
Because pan-ck Ab usually can be used to increase the sensitivity of epithelial tumor cells detection, the study chose MNP-pan-ck to enrich the CTCs in NSCLC patients. In the experiment, it was first verified whether four kinds of epithelial tumor cell lines expressed pan-ck protein by , the tumor cells were successfully enriched. Furthermore, the enriching of cancer cells was increased by elevating the proportion of cancer cells to PBMC (Figure 4 ). After enrichment, the H&E-stained cancer cells demonstrate that the four kinds of epithelial tumor cells are successfully separated from the mixture of cancer cells and PBMC. However, no cells from PBMC were enriched ( Figure 5 ).
Collectively, in order to mimic an in vivo environment, different kinds of epithelial tumor cells were isolated from the mixture of PBMC and cancer cells by using MNP-pan-ck in vitro. Therefore, it was thought that MNP-pan-ck might separate CTCs in the peripheral blood of NSCLC patients.
Expression of Lunx and sP-A in different cancer cells by ICC and QD methods
Because A549 and SPC-A-1 cells are derived from NSCLC, and Lunx and SP-A protein belong to lung tissue-specific proteins, it is hypothesized that A549 and SPC-A-1 lung cancer cells might also express Lunx and SP-A proteins, while liver cancer HepG2 and colon cancer HCT-8 cells do not express both proteins. To verify expression of Lunx and SP-A protein in the four kinds of cancer cells, QDs conjugated with Lunx and SP-A Ab were combined with the ICC method for detection purposes.
In our study, the traditional ICC method was used first to detect the expression of Lunx and SP-A protein in different cancer cells. We found that both A549 and SPC-A-1 cells express Lunx protein ( Figure 6A and B) and positive cell rates are 57.43% ± 2.47% and 48.26% ± 3.42%, respectively, while HepG2 and HCT-8 cells do not express Lunx protein ( Figure 6C and D) . At the same time, the results also show that only A549 cells express SP-A protein ( Figure 6E ) and its positive cell rate was 36.25% ± 2.66%, while SPC-A-1, HepG2, and HCT-8 cancer cell lines do not express SP-A protein ( Figure 6F-H) . Therefore, the results prove that Lunx and SP-A protein might be lung tissue-specific proteins and important markers of lung cancer cells.
Next, in order to assess whether QDs conjuncted with Abs showed similar results with the ICC method, QDs with singlelabeled Ab were used to detect the expression of Lunx and SP-A protein in four kinds of cancer cells. After four kinds of cancer cells were single-labeled with QD552-Lunx or QD625-SP-A, both A549 and SPC-A-1 lung cancer cells emit green fluorescence, which indicates that two kinds of lung cancer cells express Lunx protein ( Figure 7A and B) , and positive cell rates were 58.37% ± 2.54% and 50.33% ± 2.97%, respectively. On the other hand, A549 cells only emit red fluorescence ( Figure 7E ), which indicates that only A549 cells express SP-A protein and its positive cell rate is 38.28% ± 3.13%. QDs show many excellent photophysical properties. One of the most important is that they have broad absorption spectra and narrow size-tunable photoluminescent emission spectra. Thus, it is hypothesized that QDs with different Abs can be used to simultaneously check different specific markers of tumors. In order to validate this hypothesis, a combination of QD552-Lunx and QD625-SP-A was used to check the above four cancer cells in vitro. As shown in Figure 7I , A549 cells emit not only red fluorescence, but also green fluorescence, and the positive cell rates are 75.78% ± 3.21%, while the results of SPC-A-1, HepG2, and HCT-8 cells are the same as that of QDs with single-labeled Ab. Therefore, the study demonstrates that QDs with double-labeled Abs have more sensitivity than QDs with single-labeled Ab while using the ICC method.
Finally, in order to mimic an in vivo environment, QDs with double-labeled Abs were used to identify four kinds of cancer cells that had been separated from the mixture of c ancer cells and PBMC by MNP-pan-ck. Therefore, the method might contribute to the discovery of early micrometastases, prognosis evaluation, monitoring of recurrence, and preparation of individual postoperative treatments about NSCLC patients. However, further clinical trials may be warranted to assess the practicality of the method. Based on the above studies, Figure 9 schematically illustrates the processes by which the MNP-pan-ck enrich the CTCs from NSCLC patients and QDs with double-labeled Abs are used simultaneously to identify CTCs. Firstly, peripheral blood of different clinical specimens was taken, and then PBMC and CTCs were successfully separated by density gradient centrifugation. After MNP-pan-ck was used to enrich the CTCs from the specimens, QDs with double-labeled Abs were used simultaneously to identify the CTCs.
Detection of CTCs from NsCLC patients by MNPs and QDs
Conclusion
In this study, the synthesized MNPs were effectively coupled with pan-ck Ab, and two kinds of synthesized QDs were conjugated with Lunx and SP-A Abs. QDs with double-labeled Abs were first used simultaneously to identify the CTCs of NSCLC patients collected by MNP-pan-ck. Therefore, a new method of screening micrometastases of lung cancer in peripheral blood by MNPs and QDs was successfully developed. Abbreviations: MNPs, magnetic nanoparticles; QDs, quantum dots; NsCLC, nonsmall cell lung cancer; BLD, benign lung diseases. Note: In NsCLC, stage I means that the cancer is only in the lung, with normal tissue around it. stage II means that the cancer has spread to nearby lymph nodes. stage III means that the cancer has spread to the chest wall or diaphragm near the lung; to the lymph nodes in the area separating the two lungs (the mediastinum); or to the lymph nodes on the other side of the chest or in the neck. stage IV means that the cancer has spread to other parts of the body. Collectively, stages II-IV mean that the cancer has metastasized. 
